Casdin Capital, LLC Agios Pharmaceuticals, Inc. Transaction History

Casdin Capital, LLC

$1.29 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $22.3 Million - $41 Million	-1,305,000 Reduced 62.44%	785,000 $17.4 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $2.22 Million - $3.73 Million	-75,000 Reduced 3.46%	2,090,000 $68.7 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $9.29 Million - $12.1 Million	-210,000 Reduced 8.84%	2,165,000 $112 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $20.8 Million - $29.1 Million	625,000 Added 35.71%	2,375,000 $103 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $23 Million - $38 Million	680,000 Added 63.55%	1,750,000 $61.3 Million
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $7.72 Million - $13.2 Million	245,000 Added 29.7%	1,070,000 $38 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $3.31 Million - $5.56 Million	-110,000 Reduced 11.76%	825,000 $39.4 Million
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $14.3 Million - $21.8 Million	440,000 Added 88.89%	935,000 $30.3 Billion
Q2 2019 Aug 13, 2019	BUY	$46.17 - $68.1 $7.39 Million - $10.9 Million	160,000 Added 47.76%	495,000 $0
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $5.05 Million - $7.44 Million	-110,000 Reduced 24.72%	335,000 $22.6 Million
Q4 2018 Feb 13, 2019	SELL	$42.73 - $76.53 $5.76 Million - $10.3 Million	-134,776 Reduced 23.25%	445,000 $20.5 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $15.4 Million - $19.8 Million	215,000 Added 58.94%	579,776 $44.7 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $4.17 Million - $6.04 Million	69,776 Added 23.65%	364,776 $29.8 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $2.08 Million - $2.89 Million	40,000 Added 15.69%	295,000 $16.9 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $14 Million - $17.1 Million	255,000	255,000 $17 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$190 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$186 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$163 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$126 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$95.2 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Account